8158 logo

China Regenerative Medicine International Limited Stock Price

SEHK:8158 Community·HK$164.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

8158 Share Price Performance

HK$0.54
0.16 (42.11%)
HK$0.54
0.16 (42.11%)
Price HK$0.54

8158 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Acceptable track record with very low risk.

2 Risks
1 Reward

China Regenerative Medicine International Limited Key Details

HK$58.2m

Revenue

HK$22.2m

Cost of Revenue

HK$36.0m

Gross Profit

HK$34.8m

Other Expenses

HK$1.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.0042
61.91%
2.18%
175.7%
View Full Analysis

About 8158

Founded
1995
Employees
24
CEO
Chuang Wang
WebsiteView website
www.crmi.hk

China Regenerative Medicine International Limited, an investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China. The company operates through Aesthetic Medical and Beauty Services; and Medical Services segments. It offers medical beauty products and services; and medical products and services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.

Recent 8158 News & Updates

Recent updates

No updates